Literature DB >> 19746947

Theoretical assessment of norfloxacin redox and photochemistry.

Klefah A K Musa1, Leif A Eriksson.   

Abstract

Norfloxacin, 1-ethyl-6-fluoro-1,4-dihydo-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid, NOR, is an antibiotic drug from the fluoroquinoline family. The different protonation states of this drug formed throughout the pH range is studied by means of density functional theory (DFT) and the spectra of the NOR species computed using time-dependent DFT. Details about their photochemistry are obtained from investigating the highest occupied and lowest unoccupied molecular orbitals. The predominant species under physiological pH, the zwitterion, is the most photoliable one, capable of producing singlet oxygen or/and superoxide radical anions from its triplet state. In addition, the main photodegradation step, defluorination, occurs more easily from this species compared with the other forms. The defluorination from the excited triplet state requires passing a barrier of 16.3 kcal/mol in the case of the zwitterion. The neutral and cationic forms display higher transition barriers, whereas the reaction path of defluorination is completely endothermic for the anionic species. The theoretical results obtained herein are in line with previous experimental data.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19746947     DOI: 10.1021/jp904671s

Source DB:  PubMed          Journal:  J Phys Chem A        ISSN: 1089-5639            Impact factor:   2.781


  2 in total

1.  Effects of Magnesium, Calcium, and Aluminum Chelation on Fluoroquinolone Absorption Rate and Bioavailability: A Computational Study.

Authors:  Daniel M Walden; Maksim Khotimchenko; Hypatia Hou; Kaushik Chakravarty; Jyotika Varshney
Journal:  Pharmaceutics       Date:  2021-04-21       Impact factor: 6.321

2.  Formulation development and stability studies of norfloxacin extended-release matrix tablets.

Authors:  Paulo Renato Oliveira; Cassiana Mendes; Lilian Klein; Maximiliano da Silva Sangoi; Larissa Sakis Bernardi; Marcos Antônio Segatto Silva
Journal:  Biomed Res Int       Date:  2013-09-08       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.